BTX has been at the forefront of electroporation technology since we introduced the first commercially available electroporator in 1983. For over 30 years, we have made it our priority to focus only on electroporation and electrofusion. This focus has allowed us to develop the experience and expertise to supply you with a broad selection of innovative in vivo and in vitro tools to advance your research. BTX is part of the Harvard Bioscience family of companies. Harvard Bioscience (Nasdaq: HBIO) is a global developer, manufacturer and marketer of a broad range of specialized products, primarily scientific instruments.
REPORT PROJECT
Please note the appropriate reason for reporting.